Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04278118

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Led by Emory University · Updated on 2026-02-17

70

Participants Needed

1

Research Sites

614 weeks

Total Duration

On this page

Sponsors

E

Emory University

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells. A shorter duration of radiation treatment may avoid some of the delayed side effects of radiation while providing a more convenient treatment and reducing costs.

CONDITIONS

Official Title

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with benign intracranial or nerve sheath tumor, including meningiomas, pituitary adenomas, schwannomas, or WHO grade 2-3 meningiomas
  • Recommended to receive proton or photon fractionated radiation therapy
  • Signed informed consent to participate
Not Eligible

You will not qualify if you...

  • Pregnant females are excluded
  • Female participants who can have children must have a negative pregnancy test prior to therapy and agree to use effective contraception or abstain during the study
  • Prior radiation therapy overlapping the current treatment area
  • Inability to undergo magnetic resonance imaging (MRI)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, United States, 30322

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here